HTK. Kaplan-Meier 65%

Size: px
Start display at page:

Download "HTK. Kaplan-Meier 65%"

Transcription

1 Chin J Transplant Electronic Edition November 2014Vol. 8No ABO 5 UW HTK CT Kaplan-Meier Ⅰ ~ Ⅱ 9 65% % 36. 7% 30. 6% Evaluation of current combined heart-lung transplantation status in China and 10 years follow-up experience of a patient Yang ShouguoChen HaoYang ZhaohuaZhang HongqiangWang Fanshun Zhuang YaminWang Chunsheng. Department of Cardiothoracic SurgeryZhongshan Hospital of Fudan Universitythe Shanghai Institute of Cardiovascular DiseasesTransplantation Center of Fudan UniversityShanghai China Corresponding authorwang Chunsheng wang. chunsheng@ zs-hospital. sh. cn Abstract Objective To evaluate the cardiopulmonary allografts function on a heart-lung transplantation patient survived more than 10 years at Zhongshan Hospital and to summarize the status and results of current heart-lung transplantation in China. Methods A homologous heart-lung transplantation was performed on a femalediagnosed as Eisenmenger' s syndrome secondary to congenital atrial septal defect on December Heart-lung allograft was preserved with 1000 ml UW solution and 3000 ml HTK solution. Postoperative immunosuppressive therapies were managed with daclizumab + cyclosporine A + mycophenolate mofetil + corticosteroids. Cyclosporine A was transferred to tacrolimus at the 9th month and corticosteroids was withdrew at the 8th years postoperative. Prophylaxis against virus was managed with oral Valacicloviri for 3 months. Echocardiogrampulmonary DOI /cma. j. issn XD wang. chunsheng@ zs-hospital. sh. cn

2 Chin J Transplant Electronic Edition November 2014Vol. 8No function and thoracic CT were followed-up periodically. Literatures on clinical heart-lung transplantation between January 1992 and December 2013 in China were retrieved and analyzed attentively. Results The patient survived operation and experienced normal daily life during the follow-up of 10 years and 3 months. Echocardiogram showed left ventricular ejection fraction of 65%. Pulmonary function examination exhibited with signs of small airway obstruction. Howeverno severe acute allograft rejection episode was experienced. The patient was complicated with two episodes of pneumonia at the 5th week and 3. 5 years and both were cured. A total of 44 heart-lung transplantations were completed at 26 transplant centers in China mainland. Eisenmenger' s syndrome secondary to congenital heart diseases constituted most of the etiologies. The actuarial 1-yr3-yr5-yr survival rate was 39. 3% 36. 7% 30. 6% respectively. Infections and graft failure contributed to the main cause of death. Conclusion Excellent cardiopulmonary grafts preservationskilled operation technique carefully tailor immunosuppressive strategy and keep the balance of rejection and infection were key factors of long-term survival for heart-lung transplantation. Key words Heart-lung transplantation Long-term result Eisenmenger's syndrome ml 4 UW 3000 ml HTK min mg μg /L ~ 200 μg /L 9 8 ~ μg /L ppm E1 30 ng kg - 1 min Swan-Ganz 130 mmhg 1 mmhg = kpa Wood MasterScreen PFT Jaeger CT 28 ABO

3 Chin J Transplant Electronic Edition November 2014Vol. 8No CT SPSS13. 0 Kaplan-Meier Ⅰ ~ Ⅱ 1 1 a b. 7 CT c d. 9 CT 1 CT mm mm mm mmhg 1 1 d % ~ 94% CT mmhg = kpa L L FEF50% L /s FEF25% L /s % FEV1 /FVC FEF50%. 50% FEF25%. 25%

4 Chin J Transplant Electronic Edition November 2014Vol. 8No ~ % 63. 0% 50. 8% 3 17 ~ % 9. 5% 2 ~ % 2. 4% 2. 4% 4. 8% % % % 36. 7% 30. 6% 2 50% Kaplan-Meier CMV-IgM CMV

5 Chin J Transplant Electronic Edition November 2014Vol. 8No. 4 2 J 3 B J 4 J J J J HTK E J E E J J % E J J X CT J J J Yusen RDChristie JDEdwards LBet al. The registry of the International Society for Heart and Lung Transplantationthirtieth adult lung and heart-lung transplant report 2013focus themeage J. J Heart Lung Transplant J.. J J J J J J J.. J J J J

6 Chin J Transplant Electronic Edition November 2014Vol. 8No J J J J J J. J J J J J J. J J J s J J J J J J J J J J J J J J. J J J J J J J J J J J J LPD 77. J J E1 78. J. J h J Chiang CHWu KYu CPet al. Hypothermia and prostaglandin. 1 J. E1produce synergistic attenuation of ischemia-reperfusion lung J J J J C. 2009

7 Chin J Transplant Electronic Edition November 2014Vol. 8No. 4 injury J. Am J Respir Crit Care Med Takashima SKoukoulis GInokawa Het al. Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heartbeating donors J. J Thorac Cardiovasc Surg Pabla RBuda AJFlynn DMet al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion J. Circ Res Cornfield DNMilla CEHaddad IYet al. Safety of inhaled nitric oxide after lung transplantation J. J Heart Lung Transplant Radovancevic BVrtovec BThomas CDet al. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidatesj. J Heart Lung Transplant J /CD

She was 39 years old, gravida 4, para 2. She had an Idiopathic Pulmonary. Arterial Hypertension (PAH) revealed during pregnancy by a New York Heart

She was 39 years old, gravida 4, para 2. She had an Idiopathic Pulmonary. Arterial Hypertension (PAH) revealed during pregnancy by a New York Heart Case #1 (year 1992): She was 39 years old, gravida 4, para 2. She had an Idiopathic Pulmonary Arterial Hypertension (PAH) revealed during pregnancy by a New York Heart Association (NYHA) functional class

More information

Department of Surgery

Department of Surgery What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.

More information

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto Resuscitation in congenital heart disease Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto Evolution of Congenital Heart Disease Extraordinary success: Overall

More information

Pulmonary Hypertension in Sickle Cell Disease. Jorge Ramos Hematology Fellows Conference June 28, 2013

Pulmonary Hypertension in Sickle Cell Disease. Jorge Ramos Hematology Fellows Conference June 28, 2013 Pulmonary Hypertension in Sickle Cell Disease Jorge Ramos Hematology Fellows Conference June 28, 2013 Patient Presentation 28F with SCD, genotype SS. Presented to UWMC ER with 1 month progressive DOE and

More information

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care Transplant Journey Lynette Fix, RN, BAN, CCTC Objectives Identify key components of transplant evaluation process Identify the patient follow-up process Describe diseases indicated for transplantation

More information

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,

More information

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal. Drugs for the treatment of pulmonary arterial hypertension NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Drugs for the treatment of Remit / Appraisal objective: Final scope To appraise the clinical and cost effectiveness of

More information

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC

Documenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs

More information

Lung and Lobar Lung Transplant

Lung and Lobar Lung Transplant Protocol Lung and Lobar Lung Transplant (70307) Medical Benefit Effective Date: 07/01/14 Next Review Date: 03/17 Preauthorization Yes Review Dates: 09/09, 09/10, 09/11, 07/12, 03/13, 03/14, 03/15, 03/16

More information

DRG 475 Respiratory System Diagnosis with Ventilator Support. ICD-9-CM Coding Guidelines

DRG 475 Respiratory System Diagnosis with Ventilator Support. ICD-9-CM Coding Guidelines DRG 475 Respiratory System Diagnosis with Ventilator Support ICD-9-CM Coding G The below listed g are not inclusive. The coder should refer to the applicable Coding Clinic g for additional information.

More information

Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 March 7, 2014 Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Dear Sir or Madam: On behalf of the American Heart Association (AHA), including the American Stroke

More information

Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview

Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview Hospital-based SNF Coding Tip Sheet: Top 25 codes and Chapter Overview Chapter 5 - Mental, Behavioral and Neurodevelopmental Disorders (F00-F99) Classification improvements (different categories) expansions:

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information

Advanced Heart Failure & Transplantation Fellowship Program

Advanced Heart Failure & Transplantation Fellowship Program Advanced Heart Failure & Transplantation Fellowship Program Curriculum I. Patient Care When on the inpatient Heart Failure and Transplant Cardiology service, the cardiology fellow will hold primary responsibility

More information

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension Ideal risk prognosticator Easy to acquire Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension Safe -- Non-invasive Robust Gerhard-Paul Diller Astrid Lammers Division of Adult Congenital

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Acknowledgements. PAH in Children: Natural History. The Sildenafil Saga

Acknowledgements. PAH in Children: Natural History. The Sildenafil Saga The Sildenafil Saga David L. Wessel, MD Executive Vice President Chief Medical Officer Ikaria Distinguished Professor of Critical Care Children s National Medical Center Washington, DC, USA Acknowledgements

More information

Isabella Sudano & Franco Muggli

Isabella Sudano & Franco Muggli Swiss Hypertension Guidelines Isabella Sudano & Franco Muggli CoLaus, Swisshype ESC 2005 Dokumentenname Datum Seite 1 European Journal of Cardiovascular Prevention and Rehabilitation 2009 Guideline...

More information

Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire

Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire Date: RPICC Facility: CMS use only Include the following

More information

INHERIT. The Lancet Diabetes & Endocrinology In press

INHERIT. The Lancet Diabetes & Endocrinology In press INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy a Randomized Intervention Trial with losartan Anna Axelsson, Kasper Iversen, Niels Vejlstrup, Carolyn

More information

Potential Causes of Sudden Cardiac Arrest in Children

Potential Causes of Sudden Cardiac Arrest in Children Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are

More information

Wake Forest School of Medicine Department of General Surgery

Wake Forest School of Medicine Department of General Surgery Wake Forest School of Medicine Department of General Surgery TRANSPLANT SURGERY RESIDENT CURRICULUM (PGY-3) OVERVIEW This curriculum has largely been adapted from the curriculum for transplant surgery

More information

APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES

APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES APPENDIX B SAMPLE PEDIATRIC CRITICAL CARE NURSE PRACTITIONER GOALS AND OBJECTIVES The critical care nurse practitioner orientation is an individualized process based on one s previous experiences and should

More information

Congenital Diaphragmatic Hernia. Manuel A. Molina, M.D. University Hospital at Brooklyn SUNY Downstate

Congenital Diaphragmatic Hernia. Manuel A. Molina, M.D. University Hospital at Brooklyn SUNY Downstate Congenital Diaphragmatic Hernia Manuel A. Molina, M.D. University Hospital at Brooklyn SUNY Downstate Congenital Diaphragmatic Hernias Incidence 1 in 2000 to 5000 live births. 80% in the left side, 20%

More information

Chapter 24: Renal Transplantation in the Older Adult

Chapter 24: Renal Transplantation in the Older Adult Chapter 24: Renal Transplantation in the Older Adult Erica L. Hartmann Abdominal Organ Transplant Program, Department of Internal Medicine-Nephrology, Wake Forest University Health Sciences, Winston-Salem,

More information

Active Clinical Trials

Active Clinical Trials Active Clinical Trials 1. Genentech Efalizumab Protocol No. ACD4230g Title: A Phase II/III, Randomized, Open-Label, Active-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Efalizumab

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Management of exacerbations in chronic obstructive pulmonary disease in Primary Care

Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality.

More information

PLAN OF ACTION FOR. Physician Name Signature License Date

PLAN OF ACTION FOR. Physician Name Signature License Date PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes

More information

Thoracoabdominal aortic aneurysm

Thoracoabdominal aortic aneurysm Thoracoabdominal aortic aneurysm Patient (1) - 69 PMH: 2013 - MVP, aortic root replacement with biological valve (Perimount) and subtotal aortic arch replacement Analysis for oppressive chest complaints

More information

Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095

Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095 Hematologic Malignancies/Stem Cell Transplantation Program Clinical Section UCLA Health System Los Angeles, CA 90095 CS 6.4 DIAGNOSIS AND MANAGEMENT OF CYTOMEGALOVIRUS (CMV) INFECTION AND DISEASE Location:

More information

Tests. Pulmonary Functions

Tests. Pulmonary Functions Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic

More information

Forced vital capacity: maximal volume of air exhaled with maximally forced effort from a maximal inspiration.

Forced vital capacity: maximal volume of air exhaled with maximally forced effort from a maximal inspiration. SOP Spirometry 1. General considerations Spirometry serves as a physiological test to quantify pulmonary disease severity and to assess clinical change in respiratory function over time. Standard spirometric

More information

«Increased number of uni-ventricular hearts in adulthood. Are we ready?»

«Increased number of uni-ventricular hearts in adulthood. Are we ready?» «Increased number of uni-ventricular hearts in adulthood. Are we ready?» Augmentation du nombre de coeurs univentriculaires à l'âge adulte. Sommes nous prêts? P. Guérin L institut du thorax Nantes Increased

More information

*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS

*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS The shortage of kidney donors and the ever-increasing waiting list has prompted the transplant community to look at different types of organ donors to meet the needs of our patients on the waiting list.

More information

Patients with end-stage renal disease (ESRD) are at high

Patients with end-stage renal disease (ESRD) are at high Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures Charles A. Herzog, MD; Jennie Z. Ma, PhD; Allan J. Collins, MD Background Retrospective

More information

Lung Transplantation: An Overview of Candidacy and Outcomes

Lung Transplantation: An Overview of Candidacy and Outcomes The Ochsner Journal 14:641 648, 2014 Ó Academic Division of Ochsner Clinic Foundation Lung Transplantation: An Overview of Candidacy and Outcomes Reinaldo Rampolla, MD Multi-Organ Transplant Institute,

More information

IMPORTANT DRUG WARNING Regarding Mycophenolate-Containing Products

IMPORTANT DRUG WARNING Regarding Mycophenolate-Containing Products Dear Healthcare Provider: Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) has been mandated by the FDA (Food and Drug Administration) due to postmarketing reports showing that exposure to

More information

Prof Geert M. Verleden UZ Gasthuisberg Leuven

Prof Geert M. Verleden UZ Gasthuisberg Leuven Prof Geert M. Verleden UZ Gasthuisberg Leuven Patients with chronic end-stage lung disease, such as COPD, CF, PAH, Pulmonary fibrosis Max 50-55 y for HLTx 60-65 y for LTx Failing medical treatment Or no

More information

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital

Severe asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,

More information

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9 Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer

More information

Solid Organ Transplantation

Solid Organ Transplantation Solid Organ Transplantation Infection Prevention And Control Transplant Atlantic 2011 October 13/2011 Kathy Hart Introduction In the past several years, the drugs that we use, the surgeries themselves,

More information

Heart Failure EXERCISES. Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it.

Heart Failure EXERCISES. Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it. Heart Failure EXERCISES Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it. ) 1. Heart rate increase is a kind of economic compensation, which should

More information

Sponsor Novartis Pharmaceuticals

Sponsor Novartis Pharmaceuticals Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study

More information

TACO vs. TRALI: Recognition, Differentiation, and Investigation of Pulmonary Transfusion Reactions

TACO vs. TRALI: Recognition, Differentiation, and Investigation of Pulmonary Transfusion Reactions TACO vs. TRALI: Recognition, Differentiation, and Investigation of Pulmonary Transfusion Reactions Shealynn Harris, M.D. Assistant Medical Director American Red Cross Blood Services Southern Region Case

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

Achieving Quality and Value in Chronic Care Management

Achieving Quality and Value in Chronic Care Management The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of

More information

Appendix G - Identification and Selection of Studies

Appendix G - Identification and Selection of Studies FINAL Emergency framework for rationing of blood for massively bleeding patients during a red phase of a Appendix G - Identification and Selection of Studies Inclusion/Exclusion Criteria We included studies

More information

Pulmonary Artery Hypertension

Pulmonary Artery Hypertension Pulmonary Artery Hypertension Janet M. Pinson, RN, MSN, ACNP Maureen P. Flattery, RN, MS, ANP Virginia Commonwealth University Health System Richmond, VA Pulmonary artery hypertension (PAH) is defined

More information

PULMONARY HYPERTENSION. Charles A. Thompson, M.D., FACC, FSCAI Cardiovascular Institute of the South Zachary, Louisiana

PULMONARY HYPERTENSION. Charles A. Thompson, M.D., FACC, FSCAI Cardiovascular Institute of the South Zachary, Louisiana PULMONARY HYPERTENSION Charles A. Thompson, M.D., FACC, FSCAI Cardiovascular Institute of the South Zachary, Louisiana What is Pulmonary Hypertension? What is normal? Pulmonary artery systolic pressure

More information

CT scans and IV contrast (radiographic iodinated contrast) utilization in adults

CT scans and IV contrast (radiographic iodinated contrast) utilization in adults CT scans and IV contrast (radiographic iodinated contrast) utilization in adults At United Radiology Group, a majority of CT exams are performed either with IV contrast or without while just a few exams

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Cardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009

Cardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

NATCO Introductory Education Course Objectives

NATCO Introductory Education Course Objectives NATCO Introductory Education Course for the NEW Transplant Professional & Procurement Professional June 12-15, 2015 Tempe Mission Palms Hotel Tempe, AZ Friday, June 12, 2015 SESSION Course Participants

More information

Heart transplantation

Heart transplantation Heart transplantation A patient s guide 1 Heart transplantation Heart transplantation has the potential to significantly improve the length and quality of life for patients with severe heart failure.

More information

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate

More information

Facts about Congenital Heart Defects

Facts about Congenital Heart Defects Facts about Congenital Heart Defects Joseph A. Sweatlock, Ph.D., DABT New Jersey Department of Health Early Identification & Monitoring Program Congenital heart defects are conditions that are present

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

Certificate of Equivalence of Core Surgical Training

Certificate of Equivalence of Core Surgical Training Certificate of Equivalence of Core Surgical Training This certificate may be required to confirm the competences expected at completion of core surgical training. ALL other applicants should have this

More information

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE

More information

PFF DISEASE EDUCATION WEBINAR SERIES. Welcome!

PFF DISEASE EDUCATION WEBINAR SERIES. Welcome! PFF DISEASE EDUCATION WEBINAR SERIES Welcome! ASK A DOC Q+A WITH PFF MEDICAL TEAM Harold Collard, MD PFF Senior Medical Advisor, Research Advisory Forum Gregory Cosgrove, MD PFF Chief Medical Officer David

More information

April 2015 CALGARY ZONE CLINICAL REFERENCE PULMONARY CENTRAL ACCESS & TRIAGE

April 2015 CALGARY ZONE CLINICAL REFERENCE PULMONARY CENTRAL ACCESS & TRIAGE April 2015 CALGARY ZONE CLINICAL REFERENCE CENTRAL ACCESS & TRIAGE Introduction Pulmonary consulting services are organized through the Calgary Zone Pulmonary Central Access and Triage (PCAT). Working

More information

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Srinivasan Rajagopal M.D. Assistant Professor Division of Cardiothoracic Anesthesia Objectives Describe the pathophysiology

More information

ANAESTHESIA FOR THE PATIENT WITH PULMONARY HYPERTENSION ANAESTHESIA TUTORIAL OF THE WEEK 228

ANAESTHESIA FOR THE PATIENT WITH PULMONARY HYPERTENSION ANAESTHESIA TUTORIAL OF THE WEEK 228 ANAESTHESIA FOR THE PATIENT WITH PULMONARY HYPERTENSION ANAESTHESIA TUTORIAL OF THE WEEK 228 20 TH JUNE 2011 Dr Sarah Thomas, Senior Anaesthetic Registrar Royal Hobart Hospital Correspondence to sarah.thomas@dhhs.tas.gov.au

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,

More information

The Global Alliance against Chronic Respiratory Diseases

The Global Alliance against Chronic Respiratory Diseases The Global Alliance against Chronic Respiratory Diseases Pulmonary hypertension Dr Marc Humbert What is the burden of pulmonary hypertension? The true burden of pulmonary hypertension is currently unknown

More information

A. Begin diuretics B. Begin digoxin C. Begin B-blockers D. Endomyocardial biopsy E. None of the above

A. Begin diuretics B. Begin digoxin C. Begin B-blockers D. Endomyocardial biopsy E. None of the above 65 yo male with multiple myeloma develops dyspnea on exertion and peripheral edema. HR 80, BP 120/70. JVP > 15cm H2O. Echo notable for increased wall thickness, scintillation appearance, LVEF 50%, +1 MR

More information

The return of myocardial ischemia after coronary artery

The return of myocardial ischemia after coronary artery Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass Grafting Joseph F. Sabik III, MD; Eugene H. Blackstone, MD; A. Marc Gillinov, MD; Nicholas G. Smedira, MD; Bruce W. Lytle, MD

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy Nebulizer Medications Origination: June 17, 2009 Review Date: October 21, 2015 Next Review: October, 2017 Medicare C/D Medical Coverage Policy DESCRIPTION Nebulizer medications are used to prevent and

More information

renal transplantation: A single-center comparative study

renal transplantation: A single-center comparative study Impact of posterior urethral valves on pediatric renal transplantation: A single-center comparative study BY Mohamed Kamal Gheith, MD Oberarzt die Urologie, Universitätsmedizin Mainz Ass. Prof. of Urology,

More information

ASK A DOC. Clinical Trial Update May 28, 2014. Welcome!

ASK A DOC. Clinical Trial Update May 28, 2014. Welcome! ASK A DOC Clinical Trial Update May 28, 2014 Welcome! ASK A DOC CLINICAL TRIAL UPDATE Dr. Gregory Cosgrove PFF Chief Medical Officer Dr. Kevin Flaherty Chairman Steering Committee PFF CCN and PFF Registry

More information

Maintenance Steroid Avoidance in Pediatric Heart Transplantation is Associated with Excellent Graft Survival

Maintenance Steroid Avoidance in Pediatric Heart Transplantation is Associated with Excellent Graft Survival Maintenance Steroid Avoidance in Pediatric Heart Transplantation is Associated with Excellent Graft Survival Scott Auerbach, MD, Jane Gralla, PhD, Shelley Miyamoto, MD, David Campbell, MD, and Biagio Pietra,

More information

UNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA

UNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA SYSTEMATIC PATHOLOGY I IIIYear Scientific Field DISCIPLINE TUTOR Systematic Pathology I MED/21 MED/10 Thoracic Surgery Respiratory Diseases Tommaso Claudio Mineo Paola Rogliani MED/10 Respiratory Diseases

More information

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long

More information

THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION. feel better knowing

THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION. feel better knowing THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION feel better knowing your choice will help create more memories. Methods of Kidney Donation Kidneys for transplantation are made available through deceased

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic

More information

ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol

ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD Tips for surviving the analysis of survival data Philip Twumasi-Ankrah, PhD Big picture In medical research and many other areas of research, we often confront continuous, ordinal or dichotomous outcomes

More information

2011-2012 ACADEMIC YEAR REVISED: 9/15/11

2011-2012 ACADEMIC YEAR REVISED: 9/15/11 ELECTIVE ADDENDUM APPROVED AFTER JANUARY 1, 2011 FOR THE ACADEMIC YEAR REVISED: 9/15/11 This summary listing electives approved or renewed after January 1, 2011. They are not included in the printed version

More information

EMPHYSEMA THERAPY. Information brochure for valve therapy in the treatment of emphysema.

EMPHYSEMA THERAPY. Information brochure for valve therapy in the treatment of emphysema. EMPHYSEMA THERAPY Information brochure for valve therapy in the treatment of emphysema. PATIENTS WITH EMPHYSEMA With every breath, lungs deliver oxygen to the rest of the body to perform essential life

More information

Course Descriptions: PHTH 533 Functional Anatomy I (5)

Course Descriptions: PHTH 533 Functional Anatomy I (5) Course Descriptions: PHTH 501 Clinical Anatomy/Physiology I (5) This course is the first of three focusing on the structure of the human body and its related function. This course is designed to provide

More information

CF ATLANTA Research & Development Program at Emory University and Georgia Tech (CF@LANTA) Clinical & Translational Research Core

CF ATLANTA Research & Development Program at Emory University and Georgia Tech (CF@LANTA) Clinical & Translational Research Core CF ATLANTA Research & Development Program at Emory University and Georgia Tech (CF@LANTA) Clinical & Translational Research Core Arlene Stecenko, MD Director, Emory + Children s Cystic Fibrosis Care Center

More information

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic

More information

Idiopathic Pulmonary Fibrosis (IPF) Research

Idiopathic Pulmonary Fibrosis (IPF) Research Idiopathic Pulmonary Fibrosis (IPF): Why Early Referral is Critical Even if Your Patient is Not Eligible for a Clinical Trial Idiopathic Pulmonary Fibrosis (IPF) Research Management of IPF requires a confident

More information

Statement on Disability: Pulmonary Hypertension

Statement on Disability: Pulmonary Hypertension Statement on Disability: Pulmonary Hypertension Ronald J. Oudiz, MD and Robyn J. Barst, MD on behalf of Pulmonary Hypertension Association The Scientific Leadership Council of the Pulmonary Hypertension

More information

Sudden Cardiac Arrest- Focusing on the Unsolved Problems

Sudden Cardiac Arrest- Focusing on the Unsolved Problems Sudden Cardiac Arrest- Focusing on the Unsolved Problems Wen-Jone Chen MD, PhD, FESC Professor of Medicine, Department of Emergency Medicine, National Taiwan University, Taipei, Taiwan Superintendent,

More information

Target therapies for the treatment of pulmonary arterial hypertension in Adults

Target therapies for the treatment of pulmonary arterial hypertension in Adults Paper K2 National Specialised Commissioning Group Commissioning Policy Target therapies for the treatment of pulmonary arterial hypertension in Adults POLICY PUBLISHED: 1 JULY 2008 POLICY REVISED: 14 JANUARY

More information

2014 U.S. organ and tissue transplant cost estimates and discussion

2014 U.S. organ and tissue transplant cost estimates and discussion Prepared by: T. Scott Bentley, FSA Principal and Consulting Actuary Peer Reviewed By: Steven G. Hanson, ASA Actuary 2014 U.S. organ and tissue transplant cost estimates and discussion Prepared by: T. Scott

More information